Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | HEATR5A | CTRPv2 | pan-cancer | AAC | -0.096 | 0.008 |
mRNA | ACSL6 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.008 |
mRNA | TPR | CTRPv2 | pan-cancer | AAC | 0.092 | 0.008 |
mRNA | NBPF19 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.008 |
mRNA | RUNX3 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
mRNA | ROR1 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.008 |
mRNA | GFI1B | CTRPv2 | pan-cancer | AAC | 0.09 | 0.008 |
mRNA | MYB | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |
mRNA | KLRG2 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
mRNA | PMP22 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.008 |